Business description
The Siegfried Group is a global life sciences company with facilities located in Switzerland, the USA, Malta, China, Germany and France. Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R& D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
Management board & Supervisory board
| CEO |
| Marcel Imwinkelried |
| Management board |
| Reto Suter, Henrik Krüpper, Dr. Jürgen Roos, Marianne Späne, Irene Wosgien |
| Supervisory board |
| Dr. Andreas Casutt, Dr. Martin Schmid, Alexandra Brand, Wolfram Carius, Elodie Carr-Cingari, Beat Walti, Isabelle Welton |
Company data
| Name: |
Siegfried Holding AG |
| Address: |
Untere Brühlstraße 4,CH-4800 Zofingen |
| Phone: |
+41-62-746-1111 |
| Fax: |
+41-62-746-1202 |
| E-mail: |
info@siegfried.ch
|
| Internet: |
www.siegfried.ch |
| Industry: |
Commodities |
| Sector: |
Chemicals |
| Sub sector: |
- |
| End of financial year: |
12/31 |
| Free Float: |
75.10% |
| IPO date: |
- |
